Atea PharmaceuticalsAVIR
那斯達克 · USD
4.56
+0.07
(+1.45%)
盤中 06/30 01:04 (UTC+8)
06/30 01:04 (UTC+8)
Atea PharmaceuticalsAVIR
4.56
+0.07
(+1.45%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 48,008 | 54,934 | 45,567 | 41,345 | 39,041 | - | - | - | - | 46,573 |
研發費用 | 41,134 | 47,818 | 38,347 | 32,275 | 29,584 | 25,671 | 26,159 | 34,696 | 57,575 | 35,045 |
推銷及管理費用 | 6,874 | 7,116 | 7,220 | 9,070 | 9,457 | 13,355 | 11,043 | 12,220 | 12,231 | 11,528 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -48,008 | -54,934 | -45,567 | -41,345 | -39,041 | -39,026 | -37,202 | -46,916 | -69,806 | -46,573 |
其他收入及費用 | 2,618 | 3,299 | 3,714 | 4,391 | 4,972 | 5,708 | 6,277 | 6,637 | 6,868 | 7,758 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -45,390 | -51,635 | -41,853 | -36,954 | -34,069 | -33,318 | -30,925 | -40,279 | -62,938 | -38,815 |
所得稅 | 50 | -6,768 | 196 | 207 | 203 | 225 | 226 | 243 | 231 | 349 |
稅後純益 | -45,440 | -44,867 | -42,049 | -37,161 | -34,272 | -33,543 | -31,151 | -40,522 | -63,169 | -39,164 |
基本每股稅後盈餘(元) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | - |
稀釋每股稅後盈餘(元) | -0.57 | -0.57 | -0.52 | -0.45 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 |
基本平均股數(千股) | 79198.00 | 78126.00 | 79052.00 | 83747.00 | 85159.00 | 84463.00 | 84422.00 | 84253.00 | 83916.00 | - |
稀釋平均股數(千股) | 79198.00 | 78126.00 | 79052.00 | 83747.00 | 85159.00 | 84463.00 | 84422.00 | 84253.00 | 83916.00 | - |
還原基本每股稅後盈餘(元) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | - |
還原稀釋每股稅後盈餘(元) | -0.57 | -0.57 | -0.52 | -0.45 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 |
還原基本平均股數(千股) | 79,198 | 78,126 | 79,052 | 83,747 | 85,159 | 84,463 | 84,422 | 84,253 | 83,916 | - |
還原稀釋平均股數(千股) | 79,198 | 78,126 | 79,052 | 83,747 | 85,159 | 84,463 | 84,422 | 84,253 | 83,916 | - |
EBITDA(千元) | -45,867 | -52,339 | -42,824 | -38,171 | -35,705 | -35,927 | -33,417 | -43,199 | -66,322 | -43,056 |